➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
AstraZeneca
Express Scripts
Colorcon
McKesson

Last Updated: June 19, 2021

DrugPatentWatch Database Preview

REMICADE Drug Profile


Email this page to a colleague

« Back to Dashboard

Recent Clinical Trials for REMICADE

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Cairo UniversityPhase 2
University of California, San DiegoPhase 2/Phase 3
Daniel BenjaminPhase 2

See all REMICADE clinical trials

Recent Litigation for REMICADE

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Pharmacyclics LLC v. Alvogen Pine Brook, LLC2020-03-20
Celgene Corporation v. Mylan Pharmaceuticals Inc.2020-01-02
CELGENE CORPORATION v. MYLAN PHARMACEUTICALS INC.2019-12-30

See all REMICADE litigation

PTAB Litigation
PetitionerDate
Dr. Reddy's Laboratories, Inc.2018-08-03
2017-12-20
2014-11-06

See all REMICADE litigation

Pharmacology for REMICADE

Patent Text Search: US Patents for REMICADE

These patents were identified by searching patent claims

Supplementary Protection Certificates for REMICADE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C20170010 00279 Estonia   Get Started Free PRODUCT NAME: IBRUTINIIB;REG NO/DATE: EU/1/14/945 07.07.2015
132017000135500 Italy   Get Started Free PRODUCT NAME: SARILUMAB(KEVZARA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/17/1196, 20170627
92642 Luxembourg   Get Started Free PRODUCT NAME: POMALIDOMIDE ET SES SELS, SOLVATES, HYDRATES OU STEREOISOMERES PHARMACEUTIQUEMENT ACCEPTABLES QUI EN DERIVENT (IMNOVID); FIRST REGISTRATION DATE: 20130805
2017/056 Ireland   Get Started Free PRODUCT NAME: SARILUMAB; REGISTRATION NO/DATE: EU/1/17/1196 20170623
C02041177/01 Switzerland   Get Started Free PRODUCT NAME: SARILUMAB; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66424 20.04.2018
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Johnson and Johnson
Medtronic
Merck
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.